Evaluation of a Porcine‐Derived Placental Powder Treatment for Skin Wound Healing in an In Vivo Rat Skin Defect Model

Placental-derived biomaterials are rising in popularity for use in treating severe skin injuries due to their abundant pro-healing factors which result in improved healing outcomes. Clinical use of human-derived placental products, however, is limited by high costs, donor availability, and high variability (due to age, health, and genetic factors). Porcine-derived placental biomaterials have structure and pro-healing factors similar to human placental materials, and can be mass produced on a larger scale, with reduced variability and cost. In this study, porcine-derived placental biomaterials were compared to human-derived placental biomaterials in a full-thickness skin defect rat model. Porcine-derived placental powder (PP), porcine-derived placental membrane (PM), and human-derived amniotic membrane (HM) were tested and compared to no treatment in 36 rats. At 3, 7, and 14 days, rats were euthanized, and defects were excised for H&E and picrosirius red staining. Analyses included wound area measurement, gross inflammation and histological inflammation scoring, qualitative assessments via H&E staining, and quantification of collagen in defects via picrosirius staining over the 14-day healing process. No statistical differences were found between treatment groups at each timepoint for percent difference to adjacent control defect measurements including wound area, histological inflammation scoring, and collagen quantification analyses. PP treated defects had lower gross inflammation scores compared to HM at Day 3 (p = 0.048). Trends observed in wound area measurements, gross and histological inflammation scores, and collagen quantification suggested that PP treated defects induced greater healing efficacy at earlier timepoints. Additionally, PP defects had more rapid and robust crust formation which may have contributed to improved healing outcomes based on reduced inflammation, improved hair follicle growth, re-epithelialization, collagen formation, and protection during wound dressing changes.

Authors

Institutions

Publication Details

Journal
Journal of Biomedical Materials Research Part B Applied Biomaterials
Published
2026-02-26
DOI
https://doi.org/10.1002/jbm.b.70047
Primary Topic
Wound Healing and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of a Porcine‐Derived Placental Powder Treatment for Skin Wound Healing in an In Vivo Rat Skin Defect Model

Ali Sadeghianmaryan, Alex Bryan, Andrew Blass Watson, Matthew Thomas Atwill et al.
Journal of Biomedical Materials Research Part B Applied Biomaterials
Wound Healing and Treatments
article

Evaluation of a Porcine‐Derived Placental Powder Treatment for Skin Wound Healing in an In Vivo Rat Skin Defect Model

Ali Sadeghianmaryan, Alex Bryan, Andrew Blass Watson, Matthew Thomas Atwill, SC Hall, Joel D. Bumgardner
article en

Abstract

Placental-derived biomaterials are rising in popularity for use in treating severe skin injuries due to their abundant pro-healing factors which result in improved healing outcomes. Clinical use of human-derived placental products, however, is limited by high costs, donor availability, and high variability (due to age, health, and genetic factors). Porcine-derived placental biomaterials have structure and pro-healing factors similar to human placental materials, and can be mass produced on a larger scale, with reduced variability and cost. In this study, porcine-derived placental biomaterials were compared to human-derived placental biomaterials in a full-thickness skin defect rat model. Porcine-derived placental powder (PP), porcine-derived placental membrane (PM), and human-derived amniotic membrane (HM) were tested and compared to no treatment in 36 rats. At 3, 7, and 14 days, rats were euthanized, and defects were excised for H&E and picrosirius red staining. Analyses included wound area measurement, gross inflammation and histological inflammation scoring, qualitative assessments via H&E staining, and quantification of collagen in defects via picrosirius staining over the 14-day healing process. No statistical differences were found between treatment groups at each timepoint for percent difference to adjacent control defect measurements including wound area, histological inflammation scoring, and collagen quantification analyses. PP treated defects had lower gross inflammation scores compared to HM at Day 3 (p = 0.048). Trends observed in wound area measurements, gross and histological inflammation scores, and collagen quantification suggested that PP treated defects induced greater healing efficacy at earlier timepoints. Additionally, PP defects had more rapid and robust crust formation which may have contributed to improved healing outcomes based on reduced inflammation, improved hair follicle growth, re-epithelialization, collagen formation, and protection during wound dressing changes.

Journal of Biomedical Materials Research Part B Applied BiomaterialsVol. 114(3)
University of Memphis (US)
Good health and well-being
Openalex Percentile: Top 40%
Wound Healing and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.